[go: up one dir, main page]

KR20020040767A - 개와 고양이에서 퇴행성 관절 질환으로 인한 통증을경감시키기 위한 플루피르틴의 용도 - Google Patents

개와 고양이에서 퇴행성 관절 질환으로 인한 통증을경감시키기 위한 플루피르틴의 용도 Download PDF

Info

Publication number
KR20020040767A
KR20020040767A KR1020027001445A KR20027001445A KR20020040767A KR 20020040767 A KR20020040767 A KR 20020040767A KR 1020027001445 A KR1020027001445 A KR 1020027001445A KR 20027001445 A KR20027001445 A KR 20027001445A KR 20020040767 A KR20020040767 A KR 20020040767A
Authority
KR
South Korea
Prior art keywords
available salt
flupyritin
flupyrutin
dogs
therapeutically available
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020027001445A
Other languages
English (en)
Korean (ko)
Inventor
엔들러가브리엘레
레만홀거
로비쉬미하엘
슈첼렌니이슈트판
Original Assignee
아베데 파르마 게엠베하 운트 콤파니 카게
빌프리더 하이더
바이엘 악티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아베데 파르마 게엠베하 운트 콤파니 카게, 빌프리더 하이더, 바이엘 악티엔게젤샤프트 filed Critical 아베데 파르마 게엠베하 운트 콤파니 카게
Publication of KR20020040767A publication Critical patent/KR20020040767A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020027001445A 1999-08-03 2000-07-29 개와 고양이에서 퇴행성 관절 질환으로 인한 통증을경감시키기 위한 플루피르틴의 용도 Withdrawn KR20020040767A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14703399P 1999-08-03 1999-08-03
US60/147,033 1999-08-03
PCT/EP2000/007356 WO2001008682A2 (fr) 1999-08-03 2000-07-29 Utilisation de flupirtine pour apaiser les douleurs dues aux maladies degeneratives des articulations chez les chiens et les chats

Publications (1)

Publication Number Publication Date
KR20020040767A true KR20020040767A (ko) 2002-05-30

Family

ID=22520069

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020027001445A Withdrawn KR20020040767A (ko) 1999-08-03 2000-07-29 개와 고양이에서 퇴행성 관절 질환으로 인한 통증을경감시키기 위한 플루피르틴의 용도

Country Status (20)

Country Link
EP (1) EP1242078A2 (fr)
JP (1) JP2003530308A (fr)
KR (1) KR20020040767A (fr)
CN (1) CN1399550A (fr)
AR (1) AR025030A1 (fr)
AU (1) AU7271700A (fr)
BR (1) BR0012942A (fr)
CA (1) CA2314746A1 (fr)
CO (1) CO5180569A1 (fr)
CZ (1) CZ2002411A3 (fr)
HR (1) HRP20020192A2 (fr)
HU (1) HUP0301296A2 (fr)
IL (1) IL147667A0 (fr)
MX (1) MXPA02000997A (fr)
NO (1) NO20020364D0 (fr)
PL (1) PL354484A1 (fr)
RU (1) RU2002105502A (fr)
SK (1) SK1712002A3 (fr)
WO (1) WO2001008682A2 (fr)
ZA (1) ZA200200493B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010151004A3 (fr) * 2009-06-23 2011-05-19 Yeo Oh-Young Composition injectable contenant de l'hydroxychloroquine destinée à une administration locale pour le traitement des hémorroïdes

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10312346A1 (de) 2003-03-20 2004-09-30 Bayer Healthcare Ag Kontrolliertes Freisetzungssystem
AU2004298288B2 (en) * 2003-12-16 2011-06-30 Relevare Aust. Pty Ltd Methods and compositions
CA2550023C (fr) * 2003-12-16 2011-04-12 Cnsbio Pty Ltd Traitement de la douleur neuropathique
US7553858B2 (en) * 2003-12-17 2009-06-30 Meda Pharma Gmbh & Co. Kg Combination of flupirtine and tramadol
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
US20060052370A1 (en) * 2004-08-24 2006-03-09 Meyerson Laurence R Methods and compositions for treating nociceptive pain
ITMI20120896A1 (it) * 2012-05-23 2013-11-24 Bongulielmi Reto Condroitina per uso in medicina
CN104523634A (zh) * 2014-11-21 2015-04-22 哈尔滨圣吉药业股份有限公司 一种马来酸氟吡汀缓释片及其制备方法
RU2680244C1 (ru) * 2017-12-28 2019-02-19 Общество С Ограниченной Ответственностью "Валента-Интеллект" Комбинации флупиртина и циклобензаприна для лечения болевых синдромов
CN111371527B (zh) 2018-12-25 2021-08-13 华为技术有限公司 一种数据传输方法及通信设备

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3665538D1 (en) * 1985-01-23 1989-10-19 Asta Pharma Ag Synergistic combination of flupirtin and non-steroidal anti-phlogistics
FI855016A7 (fi) * 1985-06-28 1986-12-29 Degussa Flupirtiinin ja 4-asetamido-fenolin synergistinen yhdistelmä.
IN172468B (fr) * 1990-07-14 1993-08-14 Asta Medica Ag
DE4236752A1 (de) * 1992-10-30 1994-05-05 Asta Medica Ag Kombinationspräparat aus Flupirtin und Morphin zur Behandlung von Schmerzen und zur Vermeidung der Morphin-Abhängigkeit

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010151004A3 (fr) * 2009-06-23 2011-05-19 Yeo Oh-Young Composition injectable contenant de l'hydroxychloroquine destinée à une administration locale pour le traitement des hémorroïdes
KR101067443B1 (ko) * 2009-06-23 2011-09-27 여오영 하이드록시클로로퀸을 함유하는 치핵 치료를 위한 국소투여용 주사제 조성물
US8871228B2 (en) 2009-06-23 2014-10-28 Oh-Young Yeo Injectable composition containing hydroxychloroquine for local administration for treating hemorrhoids

Also Published As

Publication number Publication date
NO20020364L (no) 2002-01-23
CZ2002411A3 (cs) 2003-03-12
NO20020364D0 (no) 2002-01-23
ZA200200493B (en) 2003-04-30
BR0012942A (pt) 2002-07-09
CN1399550A (zh) 2003-02-26
IL147667A0 (en) 2002-08-14
EP1242078A2 (fr) 2002-09-25
SK1712002A3 (en) 2003-03-04
HUP0301296A2 (hu) 2003-08-28
AU7271700A (en) 2001-02-19
CO5180569A1 (es) 2002-07-30
AR025030A1 (es) 2002-11-06
JP2003530308A (ja) 2003-10-14
CA2314746A1 (fr) 2001-02-03
RU2002105502A (ru) 2004-03-20
WO2001008682A3 (fr) 2002-07-18
HRP20020192A2 (en) 2004-02-29
WO2001008682A2 (fr) 2001-02-08
MXPA02000997A (es) 2003-10-14
PL354484A1 (pl) 2004-01-26

Similar Documents

Publication Publication Date Title
US6767899B1 (en) Composition and method for treatment of conditions having an inflammatory component
Gaby Natural treatments for osteoarthritis
EP0550108A1 (fr) Composition thyroactive à libération contrôlée
JPH07330628A (ja) 薬剤組成物及びこれを用いた治療法
KR20020040767A (ko) 개와 고양이에서 퇴행성 관절 질환으로 인한 통증을경감시키기 위한 플루피르틴의 용도
AU2006232644B2 (en) Anti-inflammatory formulation
RU2322262C2 (ru) Композиции нестероидных противовоспалительных лекарственных средств, противозастойных средств и антигистаминов
US20120064152A1 (en) Analgesic and Anti-Inflammatory Compositions Comprising Domperidone and Methods of Using Same
TWI707678B (zh) 以週劑量療程用於哺乳動物之抗發炎及源自退化性關節疾病疼痛之吡唑啉衍生化合物及其用途
JP2013209427A (ja) ロキソプロフェン含有経口用組成物
WO2007149816A2 (fr) Compositions de strontium et méthodes de traitement d'affections ostéoporotiques
JP2001524080A (ja) 関節炎の治療用加水分解コラーゲンタンパク質およびグルコサミンを含む組成物
CZ20032256A3 (en) Medicinal compositions comprising diclofenac and ornoprostil
NO774400L (no) Fremgangsmaate til fremstilling av farmasoeytiske sammensetninger
US20070292535A1 (en) Strontium compositions and methods of treating arthritic and or osteoporitic conditions
EP1605929A1 (fr) Regime posologique pour anti-inflammatoires non steroidiens
CN115607588B (zh) 一种标本兼治抗痛风的芹槐提取物与非布司他药物组合物及其用途
JP4384435B2 (ja) くしゃみ抑制組成物
JP7026457B2 (ja) ロキソプロフェン又はその塩及びビタミンｂ１２類を含有する経口用医薬組成物
Evens Drug therapy reviews: Antirheumatic agents
CN116688135B (zh) 一种骨关节炎药物治疗组合物及其制备方法和应用
Roman-Blas et al. Glucosamine sulfate for knee osteoarthritis: science and evidence-based use
JP2004059579A (ja) 鎮痛剤組成物
WO2015069988A1 (fr) Traitement de la douleur chez les animaux
Jalava et al. Concentration of carprofen in the serum and the synovial fluid in rheumatoid arthritis patients

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20020201

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid